Factors Associated with Successful Mobilization and Collection of Peripheral Blood Hematopoietic Stem Cells in Autologous and Allogeneic Donors

Authors

  • Rada Grubovic Institute for Transfusion Medicine of RM, Medical Faculty, Ss. Cyril and Methodius University, Skopje
  • Borce Georgievski University Clinic of Hematology, Medical Faculty, Ss. Cyril and Methodius University, Skopje
  • Lidija Cevreska University Clinic of Hematology, Medical Faculty, Ss. Cyril and Methodius University, Skopje
  • Sonja Genadieva-Stavric University Clinic of Hematology, Medical Faculty, Ss. Cyril and Methodius University, Skopje
  • Milos R. Grubovic Institute for Transfusion Medicine of RM, Medical Faculty, Ss. Cyril and Methodius University, Skopje

DOI:

https://doi.org/10.3889/seejim.2017.20012

Keywords:

peripheral blood stem cells, hematopoietic stem cells, apheresis collection, mobilization strategy, stem cell harvesting

Abstract

BACKGROUND: Peripheral blood hematopoietic stem cells (PBSC) have largely replaced bone marrow derived stem cells in autologous transplantations, and have become the preferred source of stem cells in the majority of allogeneic transplantations. Sufficient number of mobilized and collected hematopoietic stem cells (HSC) is needed for successful hematopoietic stem cell transplantation.

MATERIAL AND METHOD: This study was performed in the Institute for Transfusion Medicine of RM and the University Clinic of Hematology from 2008 till 2016. There were 30 allogeneic and 90 autologous donors that underwent mobilization and collection of PBSC. The association between possible predictive factors such as demographic characteristics, laboratory parameters and collection parameters in both groups, and mobilization strategy and clinical characteristics in autologous donors and number of collected PBSC was analyzed.

RESULTS: There were 226 apheresis, 182 in autologous donors (mean 2, range 1-3) and 44 apheresis in 30 allogeneic donors (mean 1.5, range 1-2). The mean number of collected MNC in autologous donors was 3.09 x 108/kg and 2.85 x 106/kg CD34+ cells, and 3.23 x 108/kg MNC and 3.20 x 106/kg CD34+ cells in allogeneic donors. Significantly larger number of MNC and CD34+ cells was collected with the WBC set. There was a statistically significant correlation between the total number of collected MNC in autologous donors and platelet count before mobilization, the number of cycles in one apheresis procedure, quantity of collected graft and the number of collected MNC and CD34+ cells on the first day of harvestration. There was a statistically significant correlation between the total number of collected MNC in allogeneic donors and platelet count before mobilization, the number of cycles in one apheresis procedure, quantity of collected graft and number of MNC on first day of harvestration. There was a strong correlation between the number of collected MNC and CD34+ cells on the first harvest and the total number of collected MNC and CD34+ cells in poor mobilizers, and inverse correlation with the number of apheresis procedures. Donors who donated MNC ≤ 0.7 x 108/kg and/or ≤ 0.7 x 106/kg CD34+ cells on the first harvest (84.6%) were strong predictors of poor mobilizers.

CONCLUSION: Determining the proper level of baseline and preaheresis laboratory parameters for initiating mobilization and apheresis procedure which is safe for donors and greatly efficient in collection of PBSC is needed for optimization of these procedures, as well as for early intervention in poor mobilizers.

Downloads

Download data is not yet available.

References

Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813–1826. https://doi.org/10.1056/NEJMra052638 PMid:16641398

Mijovic A, Pamphlon D. Harvesting, processing and inventory management of peripheral blood stem cells. Asian J Transf Sci. 2006; 1(1): 16-23. https://doi.org/10.4103/0973-6247.28068 PMid:21938228 PMCid:PMC3168129

Grubovikj RM, Alavi A, Koppel A, Territo M, Schiller GJ. Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission. Cancers. 2012; 4(2): 601-617. https://doi.org/10.3390/cancers4020601 PMid:24213327 PMCid:PMC3712693

Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang. 2005; 89: 229-235. https://doi.org/10.1111/j.1423-0410.2005.00701.x PMid:16262756

Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C et al. for the European Society for Blood and Marrow Transplantation. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015; 50: 1037–1056. https://doi.org/10.1038/bmt.2015.6 PMid:25798672

Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI et al. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015; 21(11): 1863-1869. https://doi.org/10.1016/j.bbmt.2015.07.032 PMid:26256941 PMCid:PMC4830270

EBMT - European Group for Blood and Bone Marrow Transplantation. Annual Report 2016, available at: www.ebmt.org

Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2016. CIBMTR-Center for International Bone Marrow Transplantation Research, available at: http://www.cibmtr.org

Grathwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology. Haematologica. 2010; 95(4): 637-643. https://doi.org/10.3324/haematol.2009.015586 PMid:20378578 PMCid:PMC2857194

Grubovic R, Georgievski B, Cevreska L, Genadieva Stavric S, Grubovic M. Evaluation of factors that influence hematopoietic recovery in patients transplanted with peripheral blood derived stem cells. Bilt Transfuziol. 2016;62(1-2):29-37.

Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transportation. Blood. 2000;95:3702–3709. PMid:10845900

Gonclves TL, Benvegnu DM, Bonfanti G. Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation. Oxid Med Cell Longev. 2009; 2(2): 82-87. https://doi.org/10.4161/oxim.2.2.8355

Grubovic R, Georgievski B, Cevreska L, Genadieva Stavric S, Grubovic M. Analysis of factors that influence hematopoietic recovery in autologous transplanted patients with hematopoietic stem cells from peripheral blood. Open Access Maced J Med Sci. 2017; 5(3):324-331. https://doi.org/10.3889/oamjms.2017.039

Takeyama K, Ohto H. PBSC mobilization. Transfus Apher Sci. 2004;31(3):233-243. https://doi.org/10.1016/j.transci.2004.09.007 PMid:15556471

Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant. 2008;14(9):1045-1056. https://doi.org/10.1016/j.bbmt.2008.07.004 PMid:18721768

Schulz C, von Andrian UH, Massberg S. Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue. Immunol Res. 2009;44 (1-3):160-168. https://doi.org/10.1007/s12026-009-8109-6 PMid:19340403

Reddy RL. Mobilization and collection of peripheral blood progenitor cells for transplantation. Transfus Apher Sci. 2005;32(1):63-72. https://doi.org/10.1016/j.transci.2004.10.007 PMid:15737875

Moog R. Mobilization and harvesting of peripheral blood stem cells. Curr Stem Cell Res Ther. 2006;1(2):189-201. https://doi.org/10.2174/157488806776956869 PMid:18220866

Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, et al. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion. 2008;48:1106-1114. https://doi.org/10.1111/j.1537-2995.2008.01651.x PMid:18315528 PMCid:PMC3919131

Garicoa MP, Farias MG, Junior CG. Analysis of predictive factors of complete blood count for high-yield hematopoietic stem cell apheresis collection. J Mol Pathophysiol. 2014; 3(4): 47-51. https://doi.org/10.5455/jmp.20141221030312

Hansson M, Svensson A, Engervall P, Bjí¶rkholm M, Gruber A, Soderstrom T. Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration. Eur J Haematol. 1995;54:321-328. https://doi.org/10.1111/j.1600-0609.1995.tb00693.x PMid:7540148

Kozuka T, Ikeda K, Teshima T, Kojima K, Matsuo K, Bessho A, et al. Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood cell collection after G-CSF plus chemotherapy-induced mobilization. Transfusion 2002; 42:1514-1522. https://doi.org/10.1046/j.1537-2995.2002.00218.x PMid:12421227

Sinha S, Gastineau D, Micallef I, Hogan W, Ansell S, Buadi F, et al. Predicting PBSC harvest failure using circulating CD34 levels: Developing target-based cutoff points for early intervention. Bone Marrow Transplant. 2011;46:943-949. https://doi.org/10.1038/bmt.2010.236 PMid:20935680 PMCid:PMC3021104

Ford CD, Chan KJ, Reilly WF, Petersen FB. An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion. 2003;43(5):622-625. https://doi.org/10.1046/j.1537-2995.2003.00376.x PMid:12702184

Kudo Y, Minegishi M, Saito N, Itoh T, Fushimi J, Takahashi H et al. The absolute number of peripheral blood CD34+ cells predicts a timing for apheresis and progenitor cell yield in patients with hematologic malignancies and solid tumors. Tohoku J Exp Med. 2003;199(2):111-118. https://doi.org/10.1620/tjem.199.111 PMid:12705355

Makar RS, Padmanabhan A, Kim HC, Anderson C, Sugrue MW, Linenberger M. Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey. Transfus Med Rev. 2014;28(4):198-204. https://doi.org/10.1016/j.tmrv.2014.08.002 PMid:25311468

Lysak D, Koza V, Jindra P. Factors affecting PBSC mobilization and collection in healthy donors. Transfusion and Apheresis Science. 2005;33(3): 275–83. https://doi.org/10.1016/j.transci.2005.07.007 PMid:16209935

Grubovic Rastvorceva R, Georgievski B, Cevreska L, Grubovic M, Genadieva Stavric Sonja, et al. Donors and apheresis characteristics that influence collection efficiency of peripheral blood hematopoietic stem cells. IMJ Medicus. 2017;22(1): 39-49.

Corso A, Caberlon S, Pagnucco G, Klersy C, Zappasodi P, Alessandrino EP, et al. Blood stem cell collections in multiple myeloma: definition of a scoring system. Bone Marrow Transplant. 2000; 26:283-286. https://doi.org/10.1038/sj.bmt.1702514 PMid:10967566

Krieger MS, Schiller G, Berenson JR et al. Collection of peripheral blood progenitor cells (PBSC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells. Bone Marrow Transplant. 1996; 18:1-7.

Ford CD, Pace N, Lehman C. Factors affecting the efficiency of collection of CD34-positive peripheral blood cells by a blood cell separator. Transfusion. 1998;38:1046-50. https://doi.org/10.1046/j.1537-2995.1998.38111299056315.x PMid:9838936

Verlinden A, Van de Velde A, Verpooten GA, Janssen van Doorn K. Determining factors predictive of CD34+ cell collection efficiency in an effort to avoid extended and repeated apheresis sessions. J Clin Apher. 2013;28(6):404-10. https://doi.org/10.1002/jca.21292 PMid:24038114

Ketterer N, Sales G, Moullet I et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol. 1998; 103:235-242. https://doi.org/10.1046/j.1365-2141.1998.00960.x PMid:9792315

Sarkodee-Adoo C, Taran I, Guo C, Buadi F, Murthy R, Cox E, et al. Influence of preapheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis. Bone Marrow Transplant. 2003;31:851-5. https://doi.org/10.1038/sj.bmt.1704034 PMid:12748660

Mehta J, Oyama Y, Winter J, Williams S, Tallman M, Singhal S, et al. CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit. Bone Marrow Transplant. 2001;28:597-601. https://doi.org/10.1038/sj.bmt.1703197 PMid:11607773

Pastore D, Specchia G, Mestice A, Liso A, Pannunzio A, Carluccio P, et al. Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. Bone Marrow Transplant. 2004; 33: 1083-1087. https://doi.org/10.1038/sj.bmt.1704437 PMid:15077126

Besinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol. 1997; 15: 535-546.

Moskowitz CH, Glasmann GR, Wuest D, et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res. 1998: 4: 311-316. PMid:9516916

Ikeda K, Kozuka T, Harada M. Factors for PBPC collection efficiency and collection predictors. Transfus Apher Sci. 2004; 31(3):245-59. https://doi.org/10.1016/j.transci.2004.09.008 PMid:15556472

Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K et al. Mobilization of Hematopoietic Stem Cells"”Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation. Biol Blood Marrow Transplant. 2010;16: 490-99. https://doi.org/10.1016/j.bbmt.2009.11.012 PMid:19925876

Zeng F, Wei SJ, Huang HB, Huang QH, Lin QY, Fan LP et al. Analysis of the efficiency and influence factors of PBSC collection with Auto PBSC and MNC procedure of cell separator. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22(6):1684-90. PMid:25543497

Cooling L, Hoffmann S, Herrst M, Muck C, Armelagos H, Davenport R. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma. Transfusion. 2010;50(1):100-19. https://doi.org/10.1111/j.1537-2995.2009.02350.x PMid:19719472

Duong H, Bolwell B, Rybicki L, Koo A, His E, Figueroa P, et al. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield. J Clin Apher. 2011; 26:111-115. https://doi.org/10.1002/jca.20278 PMid:21647951

Downloads

Published

2017-12-26

Issue

Section

Clinical Immunology